Company / PP&E (Net)
KIORA PHARMACEUTICALS INC PP&E (Net) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E (Net)
$91.7K
FY2025
5-year range
$5.2K / $91.7K
FY2021-FY2025
Trend
+1652.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
PP&E (Net) changed +1652% YoY in FY2025, a notable deviation from the 7-year average annual change of +231%.
Based on SEC 10-K filings.
$91,672 in FY2025 with a 5-year CAGR of +24.6%.
Improved from $30,566 to $91,672 over the past 4 years.
PP&E (Net) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- +24.6%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +24.6%, indicating consistent growth.
- In FY2025, pp&e (net) increased 1652.1% year-over-year.
- Lowest pp&e (net) in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score -5.41 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E (Net)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $91.7K | +1652.1% |
| FY2024 | $5.2K | -82.9% |
| FY2021 | $30.6K | +0.0% |
| FY2020 | $30.6K | +81.4% |
| FY2019 | $16.8K | -61.3% |
| FY2018 | $43.5K | -21.9% |
| FY2017 | $55.8K | +46.6% |
| FY2016 | $38.0K | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026